Novartis Investigative Site

Red Deer, Alberta T4N 6V7

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Chronic Plaque-type Psoriasis

Studies at this site

• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis — Completed